BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 19202521)

  • 1. Update on the management of atherosclerotic renal artery disease.
    Fenstad ER; Kane GC
    Minerva Cardioangiol; 2009 Feb; 57(1):95-101. PubMed ID: 19202521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of long-term beneficial effects on blood pressure after percutaneous transluminal renal angioplasty in atherosclerotic renal artery stenosis.
    Alhadad A; Mattiasson I; Ivancev K; Lindblad B; Gottsäter A
    Int Angiol; 2009 Apr; 28(2):106-12. PubMed ID: 19367240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial.
    Cooper CJ; Murphy TP; Matsumoto A; Steffes M; Cohen DJ; Jaff M; Kuntz R; Jamerson K; Reid D; Rosenfield K; Rundback J; D'Agostino R; Henrich W; Dworkin L
    Am Heart J; 2006 Jul; 152(1):59-66. PubMed ID: 16824832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal artery revascularization improves heart failure control in patients with atherosclerotic renal artery stenosis.
    Kane GC; Xu N; Mistrik E; Roubicek T; Stanson AW; Garovic VD
    Nephrol Dial Transplant; 2010 Mar; 25(3):813-20. PubMed ID: 19666661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Atherosclerotic renal artery stenosis].
    Rammer M; Kramar R; Eber B
    Dtsch Med Wochenschr; 2007 Nov; 132(46):2458-62. PubMed ID: 17987555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stenting for atherosclerotic renal artery stenosis.
    Carr TM; Sabri SS; Turba UC; Park AW; Saad WE; Angle JF; Matsumoto AH
    Tech Vasc Interv Radiol; 2010 Jun; 13(2):134-45. PubMed ID: 20540922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal revascularization for heart failure in patients with atherosclerotic renovascular disease.
    Kalra PA
    Nephrol Dial Transplant; 2010 Mar; 25(3):661-3. PubMed ID: 20185412
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of atherosclerotic renal artery stenosis. Low dosage ACE inhibitors and angiotensin-receptor blockers are justified in certain cases].
    Alhadad A; Sterner G; Herlitz H
    Lakartidningen; 2009 Oct 28-Nov 3; 106(44):2836-8, 2840. PubMed ID: 19967962
    [No Abstract]   [Full Text] [Related]  

  • 9. Revascularization in renal artery stenosis.
    Foy A; Ruggiero NJ; Filippone EJ
    Cardiol Rev; 2012; 20(4):189-93. PubMed ID: 22314144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to manage hypertension with atherosclerotic renal artery stenosis?
    Ricco JB; Belmonte R; Illuminati G; Barral X; Schneider F; Chavent B
    J Cardiovasc Surg (Torino); 2017 Apr; 58(2):329-338. PubMed ID: 27998047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal artery stenosis: a common, treatable cause of renal failure?
    Textor SC; Wilcox CS
    Annu Rev Med; 2001; 52():421-42. PubMed ID: 11160787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contemporary management of atherosclerotic renovascular disease.
    Edwards MS; Corriere MA
    J Vasc Surg; 2009 Nov; 50(5):1197-210. PubMed ID: 19595533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal artery stenosis: pathophysiology and treatment.
    Gottam N; Nanjundappa A; Dieter RS
    Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1413-20. PubMed ID: 19900024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Part two: the vast majority of patients with atherosclerotic renal artery stenoses do not require intervention.
    Schneider F; Ricco JB
    Eur J Vasc Endovasc Surg; 2011 Aug; 42(2):139-43. PubMed ID: 21816339
    [No Abstract]   [Full Text] [Related]  

  • 15. Critical review of indications for renal artery stenting: do randomized trials give the answer?
    Schwarzwälder U; Zeller T
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):251-6. PubMed ID: 19434748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atherosclerotic renal artery stenosis: medical therapy alone or in combination with revascularization?
    Karagiannis A; Tziomalos K; Anagnostis P; Gossios T; Athyros VG
    Angiology; 2009; 60(4):397-402. PubMed ID: 19505885
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful reintroduction of previously failed ACE inhibitor therapy following stenting of atherosclerotic renovascular disease.
    Balachandran KP; Oldroyd KG
    Indian Heart J; 2008; 60(1):55-7. PubMed ID: 19212024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-stent restenosis of the renal artery in a single kidney patient: the role of ACEI in the therapeutic choice.
    Cianci R; Gigante A; Polidori L; Di Donato D; Martina P; Barbano B; Renzulli R; Zaccaria A; Fuiano G
    Angiology; 2009; 60(4):496-503. PubMed ID: 18796449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Predictors of successful renal artery revascularization in atherosclerotic renovascular disease].
    Flisiński M; Manitius J
    Pol Merkur Lekarski; 2005 Aug; 19(110):206-10. PubMed ID: 16245436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atherosclerotic renovascular disease in chronic heart failure: should we intervene?
    de Silva R; Nikitin NP; Bhandari S; Nicholson A; Clark AL; Cleland JG
    Eur Heart J; 2005 Aug; 26(16):1596-605. PubMed ID: 15919719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.